There are 2789 resources available
1081P - Hospital variation in cancer treatments and survival outcomes of advanced melanoma patients: Nation-wide quality assurance in the Netherlands
Presenter: Jesper Breeschoten
Session: ePoster Display
1082P - Phase I study of ripretinib, a broad-spectrum KIT and PDGFRA inhibitor, in patients with KIT-mutated or KIT-amplified melanoma
Presenter: Filip Janku
Session: ePoster Display
1083P - A pilot study of engineered adenovirus ONCOS-102 in combination with pembrolizumab (pembro) in checkpoint inhibitor refractory advanced or unresectable melanoma
Presenter: Alexander Shoushtari
Session: ePoster Display
Introduction
Presenter: Sebastian Kobold
Session: Synthetic immune therapy
Resources:
Slides
Webcast
Overview on synthetic immune receptors
Presenter: Hinrich Abken
Session: Synthetic immune therapy
Resources:
Slides
Webcast
Resistance mechanisms to T-cells in solid tumours
Presenter: Crystal Mackall
Session: Synthetic immune therapy
Resources:
Slides
Webcast
Discoveries in T-cell antigen receptor (TCR) recognition
Presenter: Tak Mak
Session: Synthetic immune therapy
Resources:
Slides
Webcast
Introduction
Presenter: Teresa Petrella
Session: Brain metastases: Treatment and controversies
Resources:
Webcast
Preclinical models of brain M1: Translational implications
Presenter: Manuel Valiente
Session: Brain metastases: Treatment and controversies
Resources:
Slides
Webcast
Current therapeutic regimens and future therapies
Presenter: Isabella Glitza
Session: Brain metastases: Treatment and controversies
Resources:
Slides
Webcast